There's a Doctor in the House at Dresdner RCM Biotechnology

Dresdner RCM has added Camilo Martinez to the management team of the stellar-performing (DRBNX Quote)Biotechnology fund.

Martinez has been a research analyst for the investment manager since last year and practiced internal medicine at Northeast Valley Health in 1999 and at Century Group Medicine in 1998, both in Southern California. From 1995 to 1998, he was a resident in the University of California at Los Angeles department of medicine. He is responsible for the day-to-day management of the fund with Faraz Naqvi, who has been with the fund since 1998.

Dresdner RCM Biotechnology, which holds $524 million, is up 77% for the year through Aug. 21, beating 90% of its peers.